Historique
Auteur B. GUARITA
Documents disponibles écrits par cet auteur (17)
Ajouter le résultat à votre sélection Affiner la recherche
L. MONTANARI ; B. GUARITA ; J. MOUNTENEY ; N. ZIPFEL ; R. SIMON | 2017
Dans European Addiction Research (Vol.23, n°3, July 2017) Article : PériodiqueThis paper explores European and national trends in specialised drug treatment entry for cannabis-related problems. The analysis is based on data for the years 2003-2014 from 22 European countries. Between 2003 and 2014, the overall number and p[...]
V. A. GYARMATHY ; I. GIRAUDON ; D. HEDRICH ; L. MONTANARI ; B. GUARITA ; L. WIESSING | 2009
Dans Eurosurveillance (Vol.14, n°9, 05 March 2009) Article : PériodiqueProblem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess publ[...]
OEDT = EMCDDA ; A. SARASA-RENEDO ; G. BARRIO ; L. MONTANARI ; B. GUARITA ; L. DE LA FUENTE ; M. J. BRAVO ; J. VICENTE | 2015
RapportFRANÇAIS : Ce rapport décrit les tendances en matière d'injection de drogues dans les États membres de l'UE, la Norvège et la Turquie entre 2000 et 2011, à travers une analyse des données relatives aux personnes recevant un traitement médicamen[...]
L. WIESSING ; B. GUARITA ; I. GIRAUDON ; BRUMMER-KORVENKONTIO H. ; M. SALMINEN ; COWAN S. A. | 2008
Dans Eurosurveillance (Vol.13, n°21, 22 May 2008) Article : PériodiqueENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]
OEDT = EMCDDA ; T. NÉFAU ; E. LEFRANÇOIS ; V. DETREZ ; T. SEYLER ; B. GUARITA ; ESCAPE Network | 2021
RapportThis protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes. Used syringes con[...]
L. NORDEN ; M. G. VAN VEEN ; C. LIDMAN ; I. TODOROV ; B. GUARITA ; M. KRETZSCHMAR ; L. WIESSING | 2013
Dans Substance Use and Misuse (Vol.48, n°14, 2013) Article : PériodiqueThis study assessed risk behavior and preventive measures for hepatitis C among injecting drug users in Rotterdam, the Netherlands (452 participants, 2002-2003) and Stockholm, Sweden (310 participants, 2004-2006), two cities with contrasting dru[...]
L. WIESSING ; M. J. VAN DE LAAR ; M. C. DONOGHOE ; B. GUARITA ; D. KLEMPOVA ; P. GRIFFITHS | 2008
Dans Eurosurveillance (Vol.13, n°50, 11 December 2008) Article : PériodiqueENGLISH : The human immunodeficiency virus (HIV) epidemic among injecting drug users (IDUs) shows different developments in different parts of the European region. In the countries of the European Union (EU) and the European Free Trade Associa[...]
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | 2021
RapportSince early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]
B. GUARITA ; V. BELACKOVA ; D. VAN DER GOUWE ; M. BLANKERS ; M. PAZITNY ; P. GRIFFITHS | 2021
Dans International Journal of Drug Policy (Vol.94, August 2021) Article : PériodiqueDevelopments in information technology have impacted on all areas of modern life and in particular facilitated the growth of globalisation in commerce and communication. Within the drugs area this means that both drugs discourse and drug markets[...]
L. MONTANARI ; M. PASINETTI ; B. GUARITA ; L. ROYUELA ; K. MULLIGAN ; J. VICENTE ; D. KLEMPOVA ; A. PIRONA ; A. GYARMATHY | 2013
Dans Drugs: Education, Prevention and Policy (Vol.20, n°1, February 2013) Article : PériodiqueThe aim of this article is to explore the prevalence of primary illicit stimulant use among people who enter drug treatment in Europe. Drawing on information provided by European Union treatment centres in 2009 (excluding Latvia, Lithuania, Port[...]
L. MONTANARI ; A. PIRONA ; B. GUARITA ; D. HEDRICH ; J. MOUNTENEY ; J. VICENTE | 2019
Dans Journal of Studies on Alcohol and Drugs (Suppl.18, January 2019) Article : PériodiqueENGLISH: OBJECTIVE: The article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on d[...]
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; L. MONTANARI ; B. GUARITA ; A. PIRONA ; I. GIRAUDON ; D. HEDRICH ; R. SIMON ; J. VICENTE | 2015
Document texte diversComparable and reliable information on the numbers and characteristics of those entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatme[...]
OEDT = EMCDDA ; L. MONTANARI ; B. GUARITA ; A. NOOR ; L. WIESSING ; F. GOMES ; D. HEDRICH ; A. PIRONA ; R. SIMON ; J. VICENTE | 2012
RapportFRANÇAIS : L'indicateur de demande de traitement, ou TDI (Treatment Demand Indicator), a été établi en 2000 à partir des travaux du groupe de coopération du Conseil de l'Europe pour la lutte contre l'abus et le trafic de drogues (Groupe Pompido[...]
OEDT = EMCDDA ; J. SCHETTINO ; F. LEUSCHNER ; L. KASTEN ; P. TOSSMANN ; E. HOCH ; M. FERRI ; B. GUARITA ; R. SIMON | 2015
RapportThis publication reviews the interventions used in the treatment of cannabis disorders and maps out the geography of cannabis treatment in Europe.
L. WIESSING ; G. LIKATAVICIUS ; D. HEDRICH ; B. GUARITA ; M. J. VAN DE LAAR ; J. VICENTE | 2011
Dans Eurosurveillance (Vol.16, n°48, 1 December 2011) Article : PériodiqueData on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in [...]
